Emeren Group Ltd
SOL
$1.48
-$0.01-0.67%
Weiss Ratings | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.75 | |||
Price History | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -9.76% | |||
30-Day Total Return | -24.87% | |||
60-Day Total Return | -24.87% | |||
90-Day Total Return | -38.08% | |||
Year to Date Total Return | -28.16% | |||
1-Year Total Return | -33.63% | |||
2-Year Total Return | -66.29% | |||
3-Year Total Return | -81.75% | |||
5-Year Total Return | 27.59% | |||
52-Week High % Change | -50.33% | |||
52-Week Low % Change | 5.67% | |||
Price | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $3.00 | |||
52-Week Low Price | $1.41 | |||
52-Week Low Price (Date) | Aug 05, 2024 | |||
52-Week High Price (Date) | Oct 03, 2024 | |||
Valuation | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 76.37M | |||
Enterprise Value | 129.76M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.44 | |||
Earnings Per Share Growth | -80.87% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.07 | |||
Price/Book (Q) | 0.02 | |||
Enterprise Value/Revenue (TTM) | 1.27 | |||
Price | $1.48 | |||
Enterprise Value/EBITDA (TTM) | 14.01 | |||
Enterprise Value/EBIT | 57.57 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 5.14M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 925 425 7335 | |||
Address | 149 Water Street Norwalk, CT 06854 | |||
Website | emeren.com | |||
Country | United States | |||
Year Founded | 2005 | |||
Profitability | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 2.19% | |||
Profit Margin | -2.57% | |||
Management Effectiveness | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.30% | |||
Return on Equity | -- | |||
Income Statement | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 94.99M | |||
Total Revenue (TTM) | 102.49M | |||
Revenue Per Share | $19.96 | |||
Gross Profit (TTM) | 24.41M | |||
EBITDA (TTM) | 9.26M | |||
EBIT (TTM) | 2.25M | |||
Net Income (TTM) | -2.64M | |||
Net Income Avl. to Common (TTM) | -2.64M | |||
Total Revenue Growth (Q YOY) | -7.80% | |||
Earnings Growth (Q YOY) | 162.93% | |||
EPS Diluted (TTM) | -0.44 | |||
EPS Diluted Growth (Q YOY) | 147.25% | |||
Balance Sheet | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 51.07M | |||
Cash Per Share (Q) | $9.95 | |||
Total Current Assets (Q) | 211.81M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 359.41M | |||
Current Ratio (Q) | 4.337 | |||
Book Value Per Share (Q) | $62.35 | |||
Total Assets (Q) | 470.11M | |||
Total Current Liabilities (Q) | 48.84M | |||
Total Debt (Q) | 64.62M | |||
Total Liabilities (Q) | 110.70M | |||
Total Common Equity (Q) | 319.57M | |||
Cash Flow | SOL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -3.71M | |||
Cash from Financing (TTM) | -12.26M | |||
Net Change in Cash (TTM) | -23.43M | |||
Levered Free Cash Flow (TTM) | -19.31M | |||
Cash from Operations (TTM) | -7.35M | |||